Management of dyslipidemia in coronary artery disease: the present and the future

Related Experiment Video

Updated: Jun 27, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Kyriakos Dimitriadis1, Panagiotis Theofilis, Panagiotis Iliakis

  • 1First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens.

Coronary Artery Disease
|April 29, 2024
PubMed

Insights

Rapidly lowering low-density lipoprotein cholesterol (LDL-C) after acute coronary syndrome (ACS) is crucial. This review explores early intervention strategies and emerging therapies for managing dyslipidemia in coronary artery disease (CAD).

Area of Science:

  • Cardiology
  • Lipidology
  • Pharmacology

Background:

  • Coronary artery disease (CAD) is a major cause of death globally.
  • Dyslipidemia is a key modifiable risk factor for CAD.
  • Effective management of low-density lipoprotein cholesterol (LDL-C) is vital for cardiovascular risk reduction.

Purpose of the Study:

  • To review the impact of early LDL-C reduction post-acute coronary syndrome (ACS) on cardiovascular outcomes.
  • To discuss optimal strategies for rapid LDL-C lowering after ACS.
  • To explore emerging therapies for dyslipidemia management in CAD.

Main Methods:

  • Literature review synthesizing current evidence on lipid-lowering strategies.
  • Analysis of the role of proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors in early ACS management.
  • Overview of novel therapeutic targets including bempedoic acid, lipoprotein(a), ApoC3, and angiopoietin-like protein 3.

Main Results:

  • Early and robust LDL-C reduction after ACS significantly improves cardiovascular outcomes.
  • PCSK9 inhibitors offer a valuable option for rapid LDL-C lowering post-ACS.
  • Emerging therapies show promise in addressing residual lipid risk and further optimizing dyslipidemia management.

Conclusions:

  • Intensified lipid-lowering therapy, particularly early LDL-C reduction, is essential following ACS.
  • Future therapeutic advancements hold potential to further personalize and enhance dyslipidemia treatment in CAD.
  • This review provides a clinical roadmap for optimizing lipid management in CAD patients.

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.9K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
496
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
731
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
156
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
540